The U.S. FDA has approved Johnson & Johnson’s Varipulse device for treating abnormal heart rhythms. Varipulse uses pulsed field ablation to create small scars inside the heart, disrupting electrical signals causing irregular heartbeats. It joins devices from Boston Scientific and Medtronic approved for atrial fibrillation, a condition characterized by an irregular heart rhythm. The FDA’s approval covers drug-refractory paroxysmal atrial fibrillation, where symptoms are occasional and last from minutes to hours. This news was reported by Sriparna Roy in Bengaluru and edited by Shounak Dasgupta.
VARIPULSE™ Catheter | Biosense Webster (jnjmedtech.com)
#varipulse #usfda #johnson&johnson #medicaldevices #varipulsedevice #bostonscientific #medtronic #atrialfibrillation
09 November 2024